Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release.

Autor: Ma, Yuan1,2 (AUTHOR) mayuan@hkbu.edu.hk, Xie, Duoli1 (AUTHOR), Chen, Zefeng1,2 (AUTHOR), Shen, Xinyang3 (AUTHOR), Wu, Xiaoqiu1 (AUTHOR), Ding, Feng1 (AUTHOR), Ding, Shijian1 (AUTHOR), Pan, Yufei1 (AUTHOR), Li, Fangfei1,2 (AUTHOR), Lu, Aiping1 (AUTHOR) aipinglu@hkbu.edu.hk, Zhang, Ge1 (AUTHOR) zhangge@hkbu.edu.hk
Zdroj: Journal of Translational Medicine. 7/1/2024, Vol. 22 Issue 1, p1-13. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje